Tag: 20F
Inventiva announces the filing of its 2023 Universal Registration Document and its 2023 Annual Report (“Form 20-F”) – 04/03/2024 at 10:00 p.m.
Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in the clinical development of…
Inventiva announces the filing of its 2023 Universal Registration Document and its 2023 Annual Report (“Form 20-F”) – 04/03/2024 at 10:00 p.m.
Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a biopharmaceutical company specializing in the clinical development of…
Press release: Filing of the 2023 Universal Registration Document, containing the Annual Financial Report, and the American “Form 20-F” – 02/23/2024 at 6:45 p.m.
Filing of the 2023 Universal Registration Document, containing the Annual Financial Report, and the American “Form 20-F” Paris, February 23, 2024 . Sanofi announces that it has filed its 2023…
ERYTECH announces the filing of its 2021 Universal Registration Document and its 2021 Form 20-F, as well as its 2022 financial calendar
ERYTECH announces the deposit of its 2021 Universal Registration Document and sound Form 20-F 2021, as well as its 2022 financial calendar Lyon, France), Cambridge, MA (US) the 28 april…
NANOBIOTIX ANNOUNCES HAVING FILED ITS 2021 UNIVERSAL REGISTRATION DOCUMENT CONTAINING THE ANNUAL FINANCIAL REPORT AND ITS 2021 “FORM 20-F”
Regulatory News: NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “ Company “), a French biotechnology company in late-stage clinical development, a pioneer in physics-based approaches to expand treatment options…
Inventiva announces the filing of its 2021 Universal Registration Document and its 2021 Annual Report (“Form 20-F”) – 03/11/2022 at 10:30 p.m.
Daix (France), Long Island City (New York, United States), March 11, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the clinical development of small molecules…
Inventiva announces the filing of its 2021 Universal Registration Document and its 2021 Annual Report (“Form 20-F”) – 03/11/2022 at 10:44 p.m.
Daix (France), Long Island City (New York, USA) March 11, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the clinical development of orally administered small…
Filing of the 2021 Universal Registration Document, containing the Annual Financial Report, and of the American “Form 20-F”
Filing of the Universal Registration Document 2021containing the Annual Financial Report, and the “ form 20-F” American Paris the 23 February 2022. Sanofi announces that it has filed its 2021…
Filing of the 2021 Universal Registration Document, containing the Annual Financial Report, and of the American “Form 20-F”
Filing of the Universal Registration Document 2021containing the Annual Financial Report, and the “ form 20-F” American Paris the 23 February 2022. Sanofi announces that it has filed its 2021…